http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107980043-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-164 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
| filingDate | 2016-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107980043-B |
| titleOfInvention | Polypeptides for the preparation of drugs acting on immune signal transduction and/or affecting intestinal barrier function and/or regulating metabolic state |
| abstract | Extracellular polypeptides derived from Akkermansia muciniphila have been found to be capable of modulating and/or promoting intestinal mucosal immune system function and/or maintaining and/or restoring metabolic state and/or increasing the physical properties of the intestinal mucosal barrier in mammals. completeness. The polypeptides or host cells comprising such polypeptides can be used to prevent and/or treat a variety of conditions that benefit from increased physical integrity of the intestinal mucosal barrier and/or improved intestinal mucosal immune system function and metabolic state. |
| priorityDate | 2015-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 290.